Clin2
NCT07054398Possibly a fitRecruiting

Catestatin levels in acne patients

Acne Vulgaris

Treatments studied

Part of Skin clinical trials.

This trial measures a blood protein called catestatin in people with moderate to severe acne. It aims to understand how catestatin relates to acne, which may help guide future treatments.

Summary written for real people, not researchers, by Clin2.

Phase
N/A
Enrollment
60 people
Ages
18 years to 40 years
Study type
Interventional

Who can take part

  • You have moderate or severe acne (not mild acne)
  • You are a healthy person overall
  • You are not pregnant or breastfeeding
  • You have not used oral acne medications in the last 4 weeks
  • You have not used topical acne treatments in the last 2 weeks
  • You have no history of chronic diseases such as liver, heart, or neurological problems

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT06225570Recruiting· Early Phase 1
Weekly isotretinoin vs tetracycline for moderate acne

This trial tests a weekly dose of isotretinoin (a strong acne medicine) versus a standard tetracycline antibiotic for treating moderate acne. It aims to find a simpler, effective option with fewer side effects.

Charleston, South Carolina
NCT07639073Not yet recruiting· Phase 4
Low-dose vs standard-dose isotretinoin for moderate to severe acne

This study compares two different dosages of isotretinoin (a powerful acne medication) to see which works better and causes fewer side effects. Isotretinoin is typically used for acne that hasn't improved with other treatments.

Islamabad
NCT06447480Recruiting· Phase 3
Comparing isotretinoin to standard care for moderate acne in darker skin

This trial compares oral isotretinoin (a strong acne medication) to standard treatments for people with moderate acne and darker skin tones. It aims to find which treatment works best for skin of color.

Nice, Alpes-Maritimes
NCT06869109Not yet recruiting
Blood markers in acne severity

This study measures two substances in the blood (CXCL10 and CRP) to see if they relate to acne severity. It may help understand inflammation in acne and guide future treatments.

Asyut, Asyut Governorate
NCT07250880Not yet recruiting
Ceramide blood levels in people with acne

This study is comparing levels of certain fats (ceramides) in the blood of people with acne versus healthy volunteers. Researchers want to see if these fats are linked to acne severity, which could lead to better treatments.

NCT06925386Not yet recruiting· Phase 2
Studying skin bacteria balance as a new acne treatment

This study tests whether balancing the bacteria on your skin can help treat mild to moderate acne. Researchers will take facial photos and follow your progress to see if this new approach works.

Denpasar, Bali

Hear when a new Acne Vulgaris trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.